HRSA-23-106: Integrated Maternal Health Services
Closed
This grant is closed. A newer notice from the same program is open now: Women's Initiative for Screening and Health (WISH) (HRSA-27-072). Status: Closes January 8, 2027 (62 days left). It is in our archive of Health Resources and Services Administration notices from 2023.
Health Resources and Services Administration offered grants of up to $1.8 million to the applicants described in the notice. It expected to make about 5 awards worth $9.0 million in total. Applications closed on May 24, 2023.
From the official notice on Grants.gov, last changed March 10, 2023. Checked November 7, 2026.
- Award ceiling$1.8 million
- Total funding$9.0 million
- Expected awards5
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | March 10, 2023 |
|---|---|
| Deadline | May 24, 2023 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligible applicants include any domestic public or private entity, including an Indian tribe or tribal organization (as those terms are defined at 25 U.S.C. 5304 (formerly cited as 25 U.S.C. 450b)). See 42 CFR 51a.3(a). Domestic faith-based and community-based organizations are eligible to apply.
Is this a realistic fit?
- Past Special Projects of Regional and National Significance awards averaged $1.6 million; this notice allows up to $1.8 million per award.
- No cost sharing or match is required.
What the grant funds
This notice announces the opportunity to apply for funding under the FY 2023 Integrated Maternal Health Services (IMHS) program. The purpose of this program is to foster the development and demonstration of integrated health services models, such as the Maternity Medical Home (sometimes referred to as the Pregnancy Medical Home (PMH)) which is modeled after the patient- centered medical home2. The models developed and demonstrated by this program will support comprehensive care (including clinical, ancillary, behavioral health, and support services) for pregnant and postpartum people who experience health disparities and have limited access to basic social and health care services. The IMHS initiative will be used to identify integrated health services models for future replication that will improve maternal health outcomes, advance equity, and address systemic barriers. Program Goal The overarching goal of the IMHS initiative is to improve maternal health outcomes in the United States by increasing access to quality, equitable, comprehensive care for pregnant and postpartum people who experience health disparities and have limited access to basic social and health care services. The program will work towards achieving this goal by: • Fostering collaborative relationships between health care providers, social services organizations/providers, state Medicaid programs, and state and local health departments to coordinate services and improve maternal health outcomes; • Developing and enhancing maternal health data infrastructure at the maternal health care practice and population levels; • Assessing the viability of various models that support integrated health services for pregnant and postpartum people; and, • Identifying lessons learned for future implementation.
Who has won Special Projects of Regional and National Significance grants before
From fiscal 2021 to 2025, Special Projects of Regional and National Significance (93.110) awarded $1.4 billion across 842 grant awards, an average of $1.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Zero to Three National Center for Infants, Toddlers & Families | District of Columbia | 2 | $54.3 million |
| University Hospitals Cleveland Medical Center | Ohio | 1 | $51.5 million |
| Children's National Medical Center | District of Columbia | 1 | $37.2 million |
| University of North Carolina at Chapel Hill | North Carolina | 8 | $29.1 million |
| American Academy of Pediatrics | Illinois | 8 | $26.4 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-072, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-23-106 still open?
No. It closed on May 24, 2023. A newer notice is open: HRSA-27-072, closes January 8, 2027 (62 days left).
Who can apply for Integrated Maternal Health Services?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Integrated Maternal Health Services?
Closed May 24, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $1.8 million each. About $9.0 million in total across about 5 awards.
Who has won Special Projects of Regional and National Significance grants before?
The largest recipients over five fiscal years were Zero to Three National Center for Infants, Toddlers & Families, University Hospitals Cleveland Medical Center, Children's National Medical Center. The program made 842 awards worth $1.4 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)